GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
4.770
-0.180 (-3.64%)
Jan 31, 2025, 4:00 PM EST - Market closed
GoodRx Holdings Stock Forecast
Stock Price Forecast
The 15 analysts with 12-month price forecasts for GoodRx Holdings stock have an average target of 8.75, with a low estimate of 6.00 and a high estimate of 16. The average target predicts an increase of 83.44% from the current stock price of 4.77.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for GDRX stock from 15 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 9 | 9 | 9 | 9 | 9 | 9 |
| Hold | 6 | 6 | 6 | 5 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 17 | 17 | 16 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Maintains $7 → $6.25 | Strong Buy | Maintains | $7 → $6.25 | +31.03% | Jan 10, 2025 |
| Keybanc | Keybanc | Buy Maintains $7 → $6 | Buy | Maintains | $7 → $6 | +25.79% | Jan 8, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $7 → $6 | Hold | Maintains | $7 → $6 | +25.79% | Dec 17, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $10 → $7 | Strong Buy | Maintains | $10 → $7 | +46.75% | Nov 13, 2024 |
| Barclays | Barclays | Buy Maintains $10 → $6 | Buy | Maintains | $10 → $6 | +25.79% | Nov 11, 2024 |
Financial Forecast
Revenue This Year
809.45M
from 750.27M
Increased by 7.89%
Revenue Next Year
842.09M
from 809.45M
Increased by 4.03%
EPS This Year
0.35
from -0.02
EPS Next Year
0.41
from 0.35
Increased by 16.56%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 833.7M | 886.1M | 963.3M | |||
| Avg | 809.5M | 842.1M | 901.7M | |||
| Low | 777.0M | 797.5M | 829.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 11.1% | 9.5% | 14.4% | |||
| Avg | 7.9% | 4.0% | 7.1% | |||
| Low | 3.6% | -1.5% | -1.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 0.42 | 0.49 | 0.62 | ||
| Avg | 0.35 | 0.41 | 0.49 | ||
| Low | 0.32 | 0.34 | 0.41 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 41.1% | 51.9% | ||
| Avg | - | 16.6% | 20.6% | ||
| Low | - | -2.0% | 0.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.